Skip to main content
OpenTrials

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

840 public trials 218 recruiting studies
Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Completed

A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

NCT02504645

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • WALLACE Los Angeles, California, United States
  • East Bay Rheumatology Medical San Leandro, California, United States
  • Denver Arthritis Clinic Denver, Colorado, United States
  • Arthritis and Rheumatic Disease Specialties Aventura, Florida, United States
View all 30 locations
View Trial Details
Completed

Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

NCT03427151

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • WALLACE Los Angeles, California, United States
  • East Bay Rheumatology Medical San Leandro, California, United States
  • Arthritis and Rheumatic Disease Specialties Aventura, Florida, United States
  • Innovative Health Research Las Vegas, Nevada, United States
View all 14 locations
View Trial Details
Completed

ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)

NCT02955615

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • AKH Wien Vienna, Austria
  • University Multiprofile Hospital for Active Treatment Plovdiv, Bulgaria
  • University Multiprofile Hospital Sofia, Bulgaria
  • Hopital Claude Huriez Lille, France
View all 25 locations
View Trial Details
Completed

A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

NCT02437890

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • Investigator Site Birmingham, Alabama, United States
  • Investigator Site Glendale, Arizona, United States
  • Investigator Site Phoenix, Arizona, United States
  • Investigator Site Tucson, Arizona, United States
View all 118 locations
View Trial Details
Completed

Dissemination of the Lupus Interactive Navigator

NCT02950714

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Calgary Health Sciences Centre Calgary, Alberta, Canada
  • Edmonton University of Alberta Edmonton, Alberta, Canada
  • Vancouver Arthritis Research Centre Vancouver, British Columbia, Canada
  • Winnipeg Health Sciences Centre Winnipeg, Manitoba, Canada
View Trial Details

Related conditions